In particular, lower expression of miR-141-3p/miR-200a-3p was associated with HER2-amplified, Luminal B, and Triple Negative (H-CSS cohort) or Normal Like (TCGA-BRCA cohort) breast cancer subtypes. The gene discussed is ERBB2; the disease is breast cancer.